![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Operations Research in Hospitals: Diagnosis and Prognosis
-
Article
37 COST EFFECTIVENESS OF NEONATAL INTENSIVE CARE (NIC)
The fully allocated costs of hospital care from birth to final discharge were determined and compared to survivorship in two cohorts of <1500g birth weight infants. Study infants included all 500 to 1499g babi...
-
Article
473 PRENATAL SELECTION BIAS IN THE EVALUATION OF NEONATAL INTENSIVE CARE (NIC)
Evaluation of NIC of very low birth weight infants (VLBW) has been based largely on infants treated in referral centers. The characteristics of the population of infants from which the treated infants come are...
-
Article
Multi-Attribute Health Status Classification Systems
In this article, multi-attribute approaches to the assessment of health status are reviewed with a special focus on 2 recently developed systems, the Health Utilities Index (HUI) Mark II and Mark III systems. ...
-
Article
Guidelines for Pharmacoeconomic Studies
This article reports the recommendations of the Panel on Cost Effectiveness in Health and Medicine, sponsored by the US Public Health Service, on standardised methods for conducting cost-effectiveness analyses...
-
Article
Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis
Objective: The aim of this study was to evaluate the cost effectiveness of multitherapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis.
-
Article
The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals
The first edition of the Guidelines for Economic Evaluation of Pharmaceuticals: Canada was published in November 1994. At that time, the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) was ...
-
Article
Information Barriers to the Implementation of Economic Evaluations in Japan
With increasing cost-containment pressures within healthcare systems worldwide, economic evaluations of medical technologies, particularly pharmaceuticals, are used to aid the allocation of expenditure and res...
-
Article
Why Has the Use of Health Economic Evaluation in Japan Lagged Behind that in Other Developed Countries?
The aging population and the increasing availability of new medical technologies, particularly pharmaceuticals, have led to growing pressure on governments worldwide to contain healthcare costs. Increasingly, ...
-
Article
The Development and Use of Quality-of-Life Measures to Evaluate Health Outcomes in Japan
Health outcomes measurement forms a key aspect of data collection for economic evaluations. Quality-of-life instruments provide a measure of patient-focused health outcomes. Such instruments, including the Eur...
-
Article
Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada
Until now, there has been no standardized method of performing and presenting budget impact analyses (BIAs) in Canada. Nevertheless, most drug plan managers have been requiring this economic data to inform dru...
-
Article
Open AccessWhat were they thinking when providing preference measurements for generic health states? The evidence for HUI3
Multi-attribute generic preference-based measures of health-related quality of life are used as comprehensive outcome measures. Typically preferences for health states defined by these systems are elicited fro...